SCHEMBL4876161

SCHEMBL4876161

CCC(=O)c1ccsc1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL828010 0.83 CES2 (0.54)
SCHEMBL22721318 0.82 CES1 (0.62)
SCHEMBL15988683 0.82 CES2 (0.62)
SCHEMBL4267362 0.80 HSD17B3 (0.55)
SCHEMBL6621764 0.80
SCHEMBL3041357 0.79 CES2 (0.54)
SCHEMBL12670300 0.79 SMN1; SMN2 (0.59)
SCHEMBL3466309 0.79 HSD17B3 (0.56)
SCHEMBL2264496 0.78
SCHEMBL4771815 0.78

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 85 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-106883926-B Peanut oil and preparation method thereof 丰益(上海)生物技术研发中心有限公司 2021-03-02 CN disclosed
CN-106458964-B The salt of halogen substituted heterocyclic compound 宇部兴产株式会社 2019-11-22 CN disclosed
CN-110183449-A Mnk inhibitors and methods related thereto 效应治疗股份有限公司 2019-08-30 CN disclosed
CN-106795162-B Mnk inhibitors and methods related thereto 效应治疗股份有限公司 2019-07-16 CN disclosed
CN-107207505-B Treat and prevent hepatitis b virus infected 2- oxo -6,7- dihydrobenzo [a] quinolizine -3- formic acid derivates 豪夫迈·罗氏有限公司 2018-12-14 CN disclosed
EP-3107952-B1 METHOD FOR THE GENERATION OF CHEMICAL LIBRARIES ETH ZUERICH (CH) 2018-09-26 EP disclosed
CN-107698555-A Halogen-substituted heterocyclic compounds 宇部兴产株式会社 2018-02-16 CN disclosed
CN-105164125-B 2-phenyl or 2-heteroaryl imidazo [1,2-a ] pyridine derivatives 豪夫迈·罗氏有限公司 2017-10-13 CN disclosed
CN-104884447-B Halogen-substituted heterocyclic compounds 宇部兴产株式会社 2017-10-10 CN disclosed
CN-105229009-B 2-phenylimidazo [1,2-A ] pyrimidines as imaging agents 豪夫迈·罗氏有限公司 2017-09-29 CN disclosed
US-20050176762-A1 Quinoline-4-carboxamide derivatives as NK-3 and NK-2 receptor antagonists GLAXOSMITHKLINE SPA 2005-08-11 US disclosed
US-20040180902-A1 3-Substituted quinoline-4-carboxamide derivatives as nk-3 and nk-2 receptor antagonists SMITHKLINE BEECHAM S.P.A. (IT) 2004-09-16 US disclosed
US-20040152726-A1 Quinoline-4-carboxamide derivatives as nk-3 and nk-2 receptor antagonists SMITHKLINE BEECHAM S.P.A. (IT) 2004-08-05 US disclosed
EP-1385839-A1 3-SUBSTITUTED QUINOLINE-4-CARBOXAMIDE DERIVATIVES AS NK-3 AND NK-2 RECEPTOR ANTAGONISTS GlaxoSmithKline S.p.A. (IT) 2004-02-04 EP disclosed
EP-1377567-A1 QUINOLINE-4-CARBOXAMIDE DERIVATIVES AS NK-3 AND NK-2 RECEPTOR ANTAGONISTS GlaxoSmithKline S.p.A. (IT) 2004-01-07 EP disclosed
WO-2002083663-A1 QUINOLINE-4-CARBOXAMIDE DERIVATIVES AS NK-3 AND NK-2 RECEPTOR ANTAGONISTS GLAXOSMITHKLINE S.P.A. (IT) 2002-10-24 WO disclosed
WO-2002083664-A1 3-SUBSTITUTED QUINOLINE-4-CARBOXAMIDE DERIVATIVES AS NK-3 AND NK-2 RECEPTOR ANTAGONISTS GLAXOSMITHKLINE S.P.A. (IT) 2002-10-24 WO disclosed
US-4175195-A REACTING A (HETERO-)AROMATIC KETONE, AMMONIA, AND AN UNSATURATED KETONE OR ALDEHYDE DEUTSCHE GOLD- UND SILBER-SCHEIDEANSTALT VORMALS ROESSLER (DE) 1979-11-20 US disclosed
US-4171444-A REACTING A (HETERO-)AROMATIC KETONE, AMMONIA, AND AN ALIPHATIC ALDEHYDE, DEHYDRATING-DEHYDROGENATION CATALYSTS DEUTSCHE GOLD- UND SILBER-SCHEIDEANSTALT VORMALS ROESSLER (DE) 1979-10-16 US disclosed
US-3983125-A ANTIINFLAMMATORY, ANTALGIC, ANTICLOTTING PARCOR (FR) 1976-09-28 US disclosed